PharmiWeb.com - Global Pharma News & Resources
PharmiWeb Today Story
Opella launches as an independent company to redefine the future of self-care.

France, 30 April 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of Opella, Sanofi keeping a significant shareholding with a 48.2% stake and Bpifrance owning a 1.8% stake. Opella is stepping into its next chapter with powerful backing, and a clear mission - “Health in Your Hands” - making self-care as simple as it should be.

This is not just a change of ownership. This is a bold move. As the purest and third-largest global player in the €190 billion Over-The-Counter and Vitamins, Minerals and Supplements space, Opella is set to lead in one of the most dynamic,  resilient corners of healthcare – where megatrends like aging populations, digital access, and self-care demand are rewriting the rulebook.

Opella is headquartered in France but thinks global. Its 100 brands – including Allegra/Allevia, Dulcolax, Buscopan and Cialis Together – are already trusted names in homes around the world. The self-care environment is still far too complex, leaving most people who suffer without treatment. Opella is grounded in science, with deep consumer obsession and a commitment to sustainability, to offer solutions that help people access the care they deserve.

Julie Van Ongevalle, Opella President and CEO:
“Going independent is not just a milestone. It is our moment. I am proud of our talented team of 11,000 who made this happen. With the right partners and a sharp focus, we are set to reshape how people everywhere manage their health – simply, confidently, and on their terms.”

Nick Linton, H…








Read More...
Opella launches as an independent company to redefine the future of self-care.

Articles